Skip to main content

Transcend Wealth Collective, LLC

SEC CIK
0001776082
Latest filing
Aug 4, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
5,910
Value
$536.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Transcend Wealth Collective, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,910$536.2K<0.1%+2,485+72.6%AddedHolders
Q1 20263,425$351.7K<0.1%+49+1.5%AddedHolders
Q4 20253,376$423.0K<0.1%−258−7.1%ReducedHolders
Q3 20253,634$486.7K<0.1%−942−20.6%ReducedHolders
Q2 20254,576$622.3K<0.1%−3,073−40.2%ReducedHolders
Q1 20257,649$1.01M0.1%−51−0.7%ReducedHolders
Q4 20247,700$871.0K0.1%−90−1.2%ReducedHolders
Q3 20247,790$888.2K0.1%−915−10.5%ReducedHolders
Q2 20248,705$904.5K0.1%+359+4.3%AddedHolders
Q1 20248,346$948.6K0.1%−129−1.5%ReducedHolders
Q4 20238,475$932.9K0.1%+269+3.3%AddedHolders
Q3 20238,206$794.7K0.1%+52+0.6%AddedHolders
Q2 20238,154$888.9K0.1%−205−2.5%ReducedHolders
Q1 20238,359$846.5K0.1%−214−2.5%ReducedHolders
Q4 20228,573$941.2K0.1%−28−0.3%ReducedHolders
Q3 20228,601$832.0K0.1%+100+1.2%AddedHolders
Q2 20228,501$924.0K0.1%+223+2.7%AddedHolders
Q1 20228,278$980.0K0.1%+401+5.1%AddedHolders
Q4 20217,877$1.11M0.1%+2,702+52.2%AddedHolders
Q3 20215,175$663.0K0.1%+417+8.8%AddedHolders
Q2 20214,758$550.0K0.1%+1,063+28.8%AddedHolders
Q1 20213,695$442.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.